JNK inhibitor
    1.
    发明授权
    JNK inhibitor 失效
    JNK抑制剂

    公开(公告)号:US07402595B2

    公开(公告)日:2008-07-22

    申请号:US10504132

    申请日:2003-02-12

    IPC分类号: C07D217/02 A61K31/47

    摘要: A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR3— or —CHR3—, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.

    摘要翻译: 含有异喹啉骨架或其盐的化合物的JNK抑制剂,例如下式表示的化合物,其中环A和环B各自为任选取代的苯环,X为-O-,-N-,-NR- SO 3 - 或-CHR 3 - ,R 2是酰基,任选酯化或硫酯化羧基,任选取代的氨基甲酰基或 任选取代的氨基等,虚线表示单键或双键,R 1是氢原子,任选取代的烃基,任选取代的杂环基等, 等等。

    Carbamate derivatives, process for producing the same and use thereof
    3.
    发明授权
    Carbamate derivatives, process for producing the same and use thereof 失效
    氨基甲酸酯衍生物,其制备方法及其用途

    公开(公告)号:US07109200B2

    公开(公告)日:2006-09-19

    申请号:US10416240

    申请日:2001-11-08

    摘要: Novel carbamate derivatives which are useful as drugs because of inhibiting activated blood coagulation factor X and thus exerting an anticoagulant effect. Compounds represented by the formula: wherein R1 represents a group represented by the formula: (wherein Y1 represents CH═CH, etc.), which may be substituted, etc.; the ring A represents an oxo-substituted nitrogen-containing heterocyclic ring which may be further substituted; R2 represents a hydrogen atom, optionally substituted C1-4 alkyl, etc.; R3 represents optionally substituted C1-4 alkyl, etc.; and Z represents an optionally substituted nitrogen containing heterocyclic group, etc., or salts thereof.

    摘要翻译: 新型氨基甲酸酯衍生物由于抑制活化凝血因子X而作为药物有用,因此起抗凝作用。 由下式表示的化合物:其中R 1表示由式(其中Y 1表示CH-CH等)表示的基团,其可以被取代等 。 环A表示可被进一步取代的含氧取代的含氮杂环; R 2表示氢原子,任选取代的C 1-4烷基等; R 3表示任选取代的C 1-4烷基等; Z表示任选取代的含氮杂环基等,或其盐。

    Apparatus for removing at least one acidic component from a gas
    7.
    发明授权
    Apparatus for removing at least one acidic component from a gas 失效
    用于从气体中去除至少一种酸性组分的装置

    公开(公告)号:US4719088A

    公开(公告)日:1988-01-12

    申请号:US828124

    申请日:1986-02-11

    摘要: Apparatus for removing an acidic component from a gas comprising two absorption columns for washing a crude gas by using two concentrations of alkali-containing aqueous solutions. The alkali-containing solution used in the first step has a pH of 6-13 and the solution used in the second step has a 0.3-2.5 N concentration. A specific gravity control device is used to control the concentration of the solution circulated for the second step. A pH control device is used to control the pH of the solution circulated for the first step. The pH control device controls a valve which regulates the addition of the second step solution into the tank of the first step solution as needed.

    摘要翻译: 用于通过使用两种浓度的含碱水溶液从气体中除去酸性组分的装置,包括用于洗涤粗气体的两个吸收塔。 第一工序中使用的含碱溶液的pH为6〜13,第二工序中使用的溶液的浓度为0.3〜2.5N。 使用比重控制装置来控制第二步循环的溶液的浓度。 pH控制装置用于控制第一步循环的溶液的pH值。 pH控制装置控制根据需要调节将第二步溶液添加到第一步骤溶液槽中的阀。

    Receptor antagonist
    9.
    发明申请
    Receptor antagonist 审中-公开
    受体拮抗剂

    公开(公告)号:US20070117840A1

    公开(公告)日:2007-05-24

    申请号:US10549889

    申请日:2004-03-16

    IPC分类号: A61K31/4704

    CPC分类号: A61K31/4704

    摘要: A compound represented by the formula (I): wherein ring A represents an aromatic ring; X represents a bond, oxygen, NR4 (R4 represents hydrogen, a hydrocarbon group, or a heterocyclic group), or alkylene; R1 represents a hydrocarbon group, or a heterocyclic group; R2 represents —COYR5 (Y represents a bond, alkylene, oxygen, sulfur, or NR6 (R6 represents hydrogen, a hydrocarbon group, or a heterocyclic group), and R5 represents a hydrocarbon group, or a heterocyclic group), a hydrocarbon group, or a heterocyclic group; and R3 represents a hydrocarbon group, a heterocyclic group, optionally substituted hydroxy, optionally substituted amino, or —S(O)nR7 (R7 represents a hydrocarbon group, or a heterocyclic group, and n is 0 to 2), a salt of the compound, or a prodrug or either is useful as an agent for modulating the function of an RFRP receptor.

    摘要翻译: 由式(I)表示的化合物:其中环A表示芳环; X表示键,氧,NR 4(R 4表示氢,烃基或杂环基)或亚烷基; R 1表示烃基或杂环基; R 2表示-COYR 5(Y表示键,亚烷基,氧,硫或NR 6(R 6) SUP>表示氢,烃基或杂环基),R 5表示烃基或杂环基),烃基或杂环基; 和R 3表示烃基,杂环基,任选取代的羟基,任选取代的氨基或-S(O)n R 7 (R 7表示烃基或杂环基,n为0〜2),化合物或前药的盐或其可用作调节其功能的试剂 RFRP受体。